搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Panax ginseng Beta-Amyrin Synthase 2 (OSCPNY2), partial CSB-YP530547EQW
CSB-EP530547EQW
CSB-BP530547EQW
CSB-MP530547EQW
CSB-EP530547EQW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Dof zinc finger protein DOF1.7 (DOF1.7) CSB-YP530548DOA
CSB-EP530548DOA
CSB-BP530548DOA
CSB-MP530548DOA
CSB-EP530548DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Probable RNA-dependent RNA polymerase 4 (RDR4), partial CSB-YP530549DOA
CSB-EP530549DOA
CSB-BP530549DOA
CSB-MP530549DOA
CSB-EP530549DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Inositol oxygenase 2 (MIOX2) CSB-YP530550DOA
CSB-EP530550DOA
CSB-BP530550DOA
CSB-MP530550DOA
CSB-EP530550DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Vesicle-associated protein 3-1 (PVA31) CSB-YP530551DOA
CSB-EP530551DOA
CSB-BP530551DOA
CSB-MP530551DOA
CSB-EP530551DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Dol-P-Man:Man (5)GlcNAc (2)-PP-Dol alpha-1,3-mannosyltransferase, partial CSB-YP530552DOA
CSB-EP530552DOA
CSB-BP530552DOA
CSB-MP530552DOA
CSB-EP530552DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Glutaredoxin-C13 (GRXC13) CSB-YP530553DOA
CSB-EP530553DOA
CSB-BP530553DOA
CSB-MP530553DOA
CSB-EP530553DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Phospholipase A1-IIbeta (At2g31100) CSB-YP530554DOA
CSB-EP530554DOA
CSB-BP530554DOA
CSB-MP530554DOA
CSB-EP530554DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Aquaporin TIP4-1 (TIP4-1), partial CSB-YP530555DOA1
CSB-EP530555DOA1
CSB-BP530555DOA1
CSB-MP530555DOA1
CSB-EP530555DOA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Desiccation-related protein At2g46140 (At2g46140) CSB-YP530556DOA
CSB-EP530556DOA
CSB-BP530556DOA
CSB-MP530556DOA
CSB-EP530556DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana F-box/kelch-repeat protein At2g29830 (At2g29830) CSB-YP530557DOA
CSB-EP530557DOA
CSB-BP530557DOA
CSB-MP530557DOA
CSB-EP530557DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana F-box/LRR-repeat/kelch-repeat protein At2g29770 (At2g29770) CSB-YP530558DOA
CSB-EP530558DOA
CSB-BP530558DOA
CSB-MP530558DOA
CSB-EP530558DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana UDP-glycosyltransferase 71C2 (UGT71C2) CSB-YP530559DOA
CSB-EP530559DOA
CSB-BP530559DOA
CSB-MP530559DOA
CSB-EP530559DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Probable malate dehydrogenase, glyoxysomal (At2g22780) CSB-YP530560DOA
CSB-EP530560DOA
CSB-BP530560DOA
CSB-MP530560DOA
CSB-EP530560DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cucumis melo var. cantalupensis Ethylene receptor 1 (ETR1), partial CSB-YP530561DZJ1
CSB-EP530561DZJ1
CSB-BP530561DZJ1
CSB-MP530561DZJ1
CSB-EP530561DZJ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Putative disease resistance protein At4g10780 (At4g10780), partial CSB-YP530562DOA
CSB-EP530562DOA
CSB-BP530562DOA
CSB-MP530562DOA
CSB-EP530562DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Protein translation factor SUI1 homolog CSB-YP530563EVU
CSB-EP530563EVU
CSB-BP530563EVU
CSB-MP530563EVU
CSB-EP530563EVU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Putative fructokinase-5 (At4g10260) CSB-YP530564DOA
CSB-EP530564DOA
CSB-BP530564DOA
CSB-MP530564DOA
CSB-EP530564DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana V-type proton ATPase subunit G1 (VHA-G1) CSB-YP530565DOA
CSB-EP530565DOA
CSB-BP530565DOA
CSB-MP530565DOA
CSB-EP530565DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Succinyl-CoA ligase [ADP-forming] subunit beta, mitochondrial (At2g20420) CSB-YP530566DOA
CSB-EP530566DOA
CSB-BP530566DOA
CSB-MP530566DOA
CSB-EP530566DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>